Maria Koehler, M.D., Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Maria Koehler, M.D., Ph.D.
Earlier roles on record: Board Member at ARS Pharmaceuticals, Inc. (SPRY) until November 8, 2022. ARS Pharmaceuticals, Inc. reported in an 8-K filed November 8, 2022 that Maria Koehler, M.D., Ph.D. resigned as director, effective November 8, 2022.
“each of Vicki L. Capps, Robert Hershberg, M.D., Ph.D., Maria Koehler, M.D., Ph.D., Andrew Powell, J.D. and Jonathan Root, M.D. resigned from the Company's board of directors and any respective committee membership of the Company's board of directors, effective as of the consummation of the Merger”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2021-03-12–2022-11-08
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.